GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Current Deferred Taxes Liabilities

CTOR (Citius Oncology) Current Deferred Taxes Liabilities : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Citius Oncology Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Citius Oncology's current deferred tax liabilities for the quarter that ended in Sep. 2024 was $0.00 Mil.

Citius Oncology Current Deferred Taxes Liabilities Historical Data

The historical data trend for Citius Oncology's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citius Oncology Current Deferred Taxes Liabilities Chart

Citius Oncology Annual Data
Trend Sep22 Sep23 Sep24
Current Deferred Taxes Liabilities
- - -

Citius Oncology Semi-Annual Data
Sep22 Sep23 Sep24
Current Deferred Taxes Liabilities - - -

Citius Oncology Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Citius Oncology's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Citius Oncology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Current Deferred Taxes Liabilities
Comparable Companies
ETST ASRT MRMD RMTI SCYX CPIX INCR SXTC RSCI INIS ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
11 Commerce Drive, First Floor, Cranford, NY, USA, 07016
Website
https://www.citiusonc.com
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.